Point72 Asset Management
TNGX icon

Point72 Asset Management’s Tango Therapeutics TNGX Stock Holding History

Point72 Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Sell
533,937
-1,440,098
-73% -$20M 0.01% 1165
2025
Q4 		$17.5M Sell
1,974,035
-945,415
-32% -$8.15M 0.02% 987
2025
Q3 		$24.5M Buy
+2,919,450
New +$19.8M 0.04% 489
2024
Q3 		– Sell
-447,107
Closed -$3.84M – 2350
2024
Q2 		$3.84M Buy
+447,107
New +$3.45M 0.01% 922
2023
Q2 		– Sell
-7,346
Closed -$29K – 2782
2023
Q1 		$29K Buy
+7,346
New +$42.6K ﹤0.01% 1907

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Point72 Asset Management's TNGX Position: Q1 2026 in Review

Point72 Asset Management reduced its Tango Therapeutics (TNGX) stake by 73% in Q1 2026, selling an estimated $20M and leaving 533,937 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #1165.

Point72 Asset Management first reported a position in TNGX in Q1 2023 and has held it in 5 quarters since. The position peaked at $24.5M in Q3 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Point72 Asset Management held 533,937 shares of Tango Therapeutics worth $11.2M as of Q1 2026.
  • Point72 Asset Management sold 1,440,098 Tango Therapeutics shares in Q1 2026, an estimated $20M.
  • Tango Therapeutics made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1165 holding.
  • Point72 Asset Management first reported a position in Tango Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Point72 Asset Management's Tango Therapeutics position peaked at $24.5M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.